1,724 results on '"Marcus, Gregory M"'
Search Results
102. Anticoagulation for Atrial Cardiopathy in Cryptogenic Stroke
- Author
-
Marcus, Gregory M., primary and Ovbiagele, Bruce, additional
- Published
- 2024
- Full Text
- View/download PDF
103. Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch
- Author
-
Avram, Robert, Ramsis, Mattheus, Cristal, Ashley D., Nathan, Viswam, Zhu, Li, Kim, Jacob, Kuang, Jilong, Gao, Alex, Vittinghoff, Eric, Rohdin-Bibby, Linnea, Yogi, Sara, Seremet, Emina, Carp, Valerie, Badilini, Fabio, Pletcher, Mark J., Marcus, Gregory M., Mortara, David, and Olgin, Jeffrey E.
- Published
- 2021
- Full Text
- View/download PDF
104. Smartwatch-Detected Atrial Fibrillation: The “Value” in the Positive Predictive Value
- Author
-
Marcus, Gregory M.
- Published
- 2022
- Full Text
- View/download PDF
105. Abstract 9803: Randomized Comparison of a Radiofrequency Wire versus a Radiofrequency Needle System for Transseptal Puncture
- Author
-
Dewland, Thomas A, GERSTENFELD, Edward, Moss, Joshua, Lee, Adam C, Vedantham, Vasanth, Lee, Randall J, Tseng, Zian, Hsia, Henry H, lee, byron K, Wall, Grace, Chang, Kathleen, Yang, Michelle, and Marcus, Gregory M
- Published
- 2022
- Full Text
- View/download PDF
106. Association Between QT-Interval Components and Sudden Cardiac Death
- Author
-
O'Neal, Wesley T, Singleton, Matthew J, Roberts, Jason D, Tereshchenko, Larisa G, Sotoodehnia, Nona, Chen, Lin Y, Marcus, Gregory M, and Soliman, Elsayed Z
- Subjects
Biomedical and Clinical Sciences ,Medical Physiology ,Cardiovascular Medicine and Haematology ,Clinical Sciences ,Clinical Research ,Heart Disease ,Cardiovascular ,Action Potentials ,Arrhythmias ,Cardiac ,Death ,Sudden ,Cardiac ,Electrocardiography ,Female ,Heart Conduction System ,Heart Rate ,Humans ,Male ,Middle Aged ,Proportional Hazards Models ,Prospective Studies ,Risk Factors ,Time Factors ,United States ,death ,sudden ,cardiac ,follow-up studies ,humans ,risk ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Clinical sciences ,Medical physiology - Abstract
Several reports have demonstrated that prolongation of the QT interval is associated with sudden cardiac death (SCD). However, it is unknown whether any of the components within the QT interval are responsible for its association with SCD. We examined the association of the individual QT-interval components (R-wave onset to R-peak, R-peak to R-wave end, ST-segment, T-wave onset to T-peak, and T-peak to T-wave end) with SCD in 12 241 participants (54±5.7 years; 26% black; 55% women) from the ARIC study (Atherosclerosis Risk in Communities). The QT interval and its components were measured at baseline (1987-1989) from 12-lead ECGs. SCD cases were adjudicated by a group of physicians through December 31, 2012. During a median follow-up of 23.6 years, a total of 346 cases of SCD were identified. Although prolongation of the QT interval was associated with a 49% increased risk of SCD (hazard ratio, 1.49; 95% confidence interval, 1.01-2.18), only the T-wave onset to T-peak component (per 1-SD increase: hazard ratio, 1.19; 95% confidence interval, 1.06-1.34) was associated with SCD and not any of the other components in separate models. When all of the QT-interval components were included in the same model, T-wave onset to T-peak remained the strongest predictor of SCD (per 1-SD increase: hazard ratio, 1.21; 95% confidence interval, 1.06-1.37). The risk of SCD with the QT interval is driven by prolongation of the T-wave onset to T-peak component. This suggests that shifting the focus from the overall QT interval to its individual components will refine SCD prediction in the community.
- Published
- 2017
107. Ectopy on a Single 12-Lead ECG, Incident Cardiac Myopathy, and Death in the Community.
- Author
-
Nguyen, Kaylin T, Vittinghoff, Eric, Dewland, Thomas A, Dukes, Jonathan W, Soliman, Elsayed Z, Stein, Phyllis K, Gottdiener, John S, Alonso, Alvaro, Chen, Lin Y, Psaty, Bruce M, Heckbert, Susan R, and Marcus, Gregory M
- Subjects
Humans ,Atrial Fibrillation ,Atrial Premature Complexes ,Ventricular Premature Complexes ,Cardiomyopathies ,Electrocardiography ,Prognosis ,Incidence ,Risk Factors ,Prospective Studies ,Aged ,Middle Aged ,United States ,Female ,Male ,Heart Failure ,atrial fibrillation ,heart failure ,mortality ,premature atrial contractions ,premature ventricular contractions ,Cardiovascular ,Heart Disease ,Patient Safety ,Aging ,Prevention ,Clinical Research ,Cardiorespiratory Medicine and Haematology - Abstract
BackgroundAtrial fibrillation and heart failure are 2 of the most common diseases, yet ready means to identify individuals at risk are lacking. The 12-lead ECG is one of the most accessible tests in medicine. Our objective was to determine whether a premature atrial contraction observed on a standard 12-lead ECG would predict atrial fibrillation and mortality and whether a premature ventricular contraction would predict heart failure and mortality.Methods and resultsWe utilized the CHS (Cardiovascular Health) Study, which followed 5577 participants for a median of 12 years, as the primary cohort. The ARIC (Atherosclerosis Risk in Communities Study), the replication cohort, captured data from 15 792 participants over a median of 22 years. In the CHS, multivariable analyses revealed that a baseline 12-lead ECG premature atrial contraction predicted a 60% increased risk of atrial fibrillation (hazard ratio, 1.6; 95% CI, 1.3-2.0; P
- Published
- 2017
108. Volunteer Participation in the Health eHeart Study: A Comparison with the US Population.
- Author
-
Guo, Xiaofan, Vittinghoff, Eric, Olgin, Jeffrey E, Marcus, Gregory M, and Pletcher, Mark J
- Subjects
Humans ,Cardiovascular Diseases ,Nutrition Surveys ,Risk Factors ,Comorbidity ,Socioeconomic Factors ,Internet ,Adult ,Aged ,Aged ,80 and over ,Middle Aged ,United States ,Female ,Male ,Young Adult ,Public Health Surveillance ,Volunteers - Abstract
Direct volunteer "eCohort" recruitment can be an efficient way of recruiting large numbers of participants, but there is potential for volunteer bias. We compared self-selected participants in the Health eHeart Study to participants in the National Health And Nutrition Examination Survey (NHANES) 2013-14, a cross-sectional survey of the US population. Compared with the US population (represented by 5,769 NHANES participants), the 12,280 Health eHeart participants with complete survey data were more likely to be female (adjusted odds ratio (ORadj) = 3.1; 95% confidence interval (CI) 2.9-3.5); less likely to be Black, Hispanic, or Asian versus White/non-Hispanic (ORadj's = 0.4-0.6, p
- Published
- 2017
109. Electrocardiographic intervals associated with incident atrial fibrillation: Dissecting the QT interval
- Author
-
Roberts, Jason D, Soliman, Elsayed Z, Alonso, Alvaro, Vittinghoff, Eric, Chen, Lin Y, Loehr, Laura, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Cardiovascular ,Heart Disease ,Action Potentials ,Atrial Fibrillation ,Electrocardiography ,Heart Conduction System ,Humans ,Atrial fibrillation ,QT interval ,Epidemiology ,Arrhythmia ,Biomedical Engineering ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundProlongation of the QT interval has been associated with an increased risk of developing atrial fibrillation (AF), but the responsible mechanism remains unknown.ObjectivesThe aims of this study were to subdivide the QT interval into its components and identify the resultant electrocardiographic interval(s) responsible for the association with AF.MethodsPredefined QT-interval components were assessed for association with incident AF in the Atherosclerosis Risk in Communities study using Cox proportional hazards models. Hazard ratios (HRs) were calculated per 1-SD increase in each component. Among QT-interval components exhibiting significant associations, additional analyses evaluating long extremes, defined as greater than the 95th percentile, were performed.ResultsOf the 14,625 individuals, 1505 (10.3%) were diagnosed with incident AF during a mean follow-up period of 17.6 years. After multivariable adjustment, QT-interval components involved in repolarization, but not depolarization, exhibited significant associations with incident AF, including a longer ST segment (HR 1.27; 95% confidence interval [CI] 1.14-1.41; P < .001) and a prolonged T-wave onset to T-wave peak (T-onset to T-peak) (HR 1.13; 95% CI 1.07-1.20; P < .001). Marked prolongation of the ST segment (HR 1.31; 95% CI 1.04-1.64; P = .022) and T-onset to T-peak (HR 1.36; 95% CI 1.09-1.69; P = .006) was also associated with an increased risk of incident AF.ConclusionThe association between a prolonged QT interval and incident AF is primarily explained by components involved in ventricular repolarization: prolongation of the ST segment and T-onset to T-peak. These observations suggest that prolongation of phases 2 and 3 of the cardiac action potential drives the association between the QT interval and AF risk.
- Published
- 2017
110. Smartphone-Based Geofencing to Ascertain Hospitalizations
- Author
-
Nguyen, Kaylin T, Olgin, Jeffrey E, Pletcher, Mark J, Ng, Madelena, Kaye, Leanne, Moturu, Sai, Gladstone, Rachel A, Malladi, Chaitanya, Fann, Amy H, Maguire, Carol, Bettencourt, Laura, Christensen, Matthew A, and Marcus, Gregory M
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Clinical Sciences ,Health Sciences ,Patient Safety ,Health Services ,Clinical Research ,Clinical Trials and Supportive Activities ,Adult ,Aged ,Appointments and Schedules ,Attitude to Computers ,Cardiac Catheterization ,Electronic Health Records ,Electrophysiologic Techniques ,Cardiac ,Feasibility Studies ,Female ,Geographic Information Systems ,Hospitalization ,Humans ,Male ,Middle Aged ,Mobile Applications ,Patient Satisfaction ,Smartphone ,Surveys and Questionnaires ,Telemedicine ,Time Factors ,United States ,fast food ,hospitalization ,internet ,pharmacies ,smartphone ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Public health - Abstract
BackgroundAscertainment of hospitalizations is critical to assess quality of care and the effectiveness and adverse effects of various therapies. Smartphones, mobile geolocators that are ubiquitous, have not been leveraged to ascertain hospitalizations. Therefore, we evaluated the use of smartphone-based geofencing to track hospitalizations.Methods and resultsParticipants aged ≥18 years installed a mobile application programmed to geofence all hospitals using global positioning systems and cell phone tower triangulation and to trigger a smartphone-based questionnaire when located in a hospital for ≥4 hours. An in-person study included consecutive consenting patients scheduled for electrophysiology and cardiac catheterization procedures. A remote arm invited Health eHeart Study participants who consented and engaged with the study via the internet only. The accuracy of application-detected hospitalizations was confirmed by medical record review as the reference standard. Of 22 eligible in-person patients, 17 hospitalizations were detected (sensitivity 77%; 95% confidence interval, 55%-92%). The length of stay according to the application was positively correlated with the length of stay ascertained via the electronic medical record (r=0.53; P=0.03). In the remote arm, the application was downloaded by 3443 participants residing in all 50 US states; 243 hospital visits at 119 different hospitals were detected through the application. The positive predictive value for an application-reported hospitalization was 65% (95% confidence interval, 57%-72%).ConclusionsMobile application-based ascertainment of hospitalizations can be achieved with modest accuracy. This first proof of concept may ultimately be applicable to geofencing other types of prespecified locations to facilitate healthcare research and patient care.
- Published
- 2017
111. Alcohol Abuse and Cardiac Disease
- Author
-
Whitman, Isaac R, Agarwal, Vratika, Nah, Gregory, Dukes, Jonathan W, Vittinghoff, Eric, Dewland, Thomas A, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Research ,Health Services ,Cardiovascular ,Prevention ,Heart Disease - Coronary Heart Disease ,Substance Misuse ,Heart Disease ,Alcoholism ,Alcohol Use and Health ,2.1 Biological and endogenous factors ,Aetiology ,Good Health and Well Being ,Alcoholism ,California ,Female ,Follow-Up Studies ,Heart Diseases ,Humans ,Incidence ,Male ,Middle Aged ,Population Surveillance ,Retrospective Studies ,Risk Assessment ,Risk Factors ,alcohol abuse ,atrial fibrillation ,congestive heart failure ,epidemiology ,myocardial infarction ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundUnderstanding the relationship between alcohol abuse, a common and theoretically modifiable condition, and the most common cause of death in the world, cardiovascular disease, may inform potential prevention strategies.ObjectivesThe study sought to investigate the associations among alcohol abuse and atrial fibrillation (AF), myocardial infarction (MI), and congestive heart failure (CHF).MethodsUsing the Healthcare Cost and Utilization Project database, we performed a longitudinal analysis of California residents ≥21 years of age who received ambulatory surgery, emergency, or inpatient medical care in California between 2005 and 2009. We determined the risk of an alcohol abuse diagnosis on incident AF, MI, and CHF. Patient characteristics modifying the associations and population-attributable risks were determined.ResultsAmong 14,727,591 patients, 268,084 (1.8%) had alcohol abuse. After multivariable adjustment, alcohol abuse was associated with an increased risk of incident AF (hazard ratio [HR]: 2.14; 95% confidence interval [CI]: 2.08 to 2.19; p < 0.0001), MI (HR: 1.45; 95% CI: 1.40 to 1.51; p < 0.0001), and CHF (HR: 2.34; 95% CI: 2.29 to 2.39; p
- Published
- 2017
112. Correction: Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study.
- Author
-
Dixit, Shalini, Alonso, Alvaro, Vittinghoff, Eric, Soliman, Elsayed Z, Chen, Lin Y, and Marcus, Gregory M
- Subjects
General Science & Technology - Abstract
[This corrects the article DOI: 10.1371/journal.pone.0185228.].
- Published
- 2017
113. Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
- Author
-
Dixit, Shalini, Alonso, Alvaro, Vittinghoff, Eric, Soliman, Elsayed, Chen, Lin Y, and Marcus, Gregory M
- Subjects
Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Health Sciences ,Cardiovascular ,Substance Misuse ,Heart Disease ,Clinical Research ,Alcoholism ,Alcohol Use and Health ,Prevention ,Atherosclerosis ,Cancer ,Oral and gastrointestinal ,Stroke ,Good Health and Well Being ,Alcohol Drinking ,Atrial Fibrillation ,Female ,Humans ,Incidence ,Kaplan-Meier Estimate ,Male ,Middle Aged ,Risk Factors ,General Science & Technology - Abstract
BackgroundAlthough current alcohol consumption is a risk factor for incident atrial fibrillation (AF), the more clinically relevant question may be whether alcohol cessation is associated with a reduced risk.Methods and resultsWe studied participants enrolled in the Atherosclerosis Risk in Communities Study (ARIC) between 1987 and 1989 without prevalent AF. Past and current alcohol consumption were ascertained at baseline and at 3 subsequent visits. Incident AF was ascertained via study ECGs, hospital discharge ICD-9 codes, and death certificates. Of 15,222 participants, 2,886 (19.0%) were former drinkers. During a median follow-up of 19.7 years, there were 1,631 cases of incident AF, 370 occurring in former consumers. Former drinkers had a higher rate of AF compared to lifetime abstainers and current drinkers. After adjustment for potential confounders, every decade abstinent from alcohol was associated with an approximate 20% (95% CI 11-28%) lower rate of incident AF; every additional decade of past alcohol consumption was associated with a 13% (95% CI 3-25%) higher rate of AF; and every additional drink per day during former drinking was associated with a 4% (95% CI 0-8%) higher rate of AF.ConclusionsAmong former drinkers, the number of years of drinking and the amount of alcohol consumed may each confer an increased risk of AF. Given that a longer duration of abstinence was associated with a decreased risk of AF, earlier modification of alcohol use may have a greater influence on AF prevention.
- Published
- 2017
114. The QT Interval as a Noninvasive Marker of Atrial Refractoriness
- Author
-
NGUYEN, KAYLIN T, GLADSTONE, RACHEL A, DUKES, JONATHAN W, NAZER, BABAK, VITTINGHOFF, ERIC, BADHWAR, NITISH, VEDANTHAM, VASANTH, GERSTENFELD, EDWARD P, LEE, BYRON K, LEE, RANDALL J, TSENG, ZIAN H, OLGIN, JEFFREY E, SCHEINMAN, MELVIN M, and MARCUS, GREGORY M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Sciences ,Heart Disease ,Clinical Research ,Cardiovascular ,Adult ,Aged ,Aged ,80 and over ,Atrial Fibrillation ,Biomarkers ,Diagnosis ,Computer-Assisted ,Electrocardiography ,Female ,Humans ,Long QT Syndrome ,Male ,Middle Aged ,Reproducibility of Results ,Risk Assessment ,Sensitivity and Specificity ,atrial fibrillation ,refractory period ,QT interval ,Biomedical Engineering ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Clinical sciences - Abstract
BackgroundAtrial refractoriness may be an important determinant of atrial fibrillation (AF) risk, but its measurement is not clinically accessible. Because the QT interval predicts incident AF and the atrium and ventricle share repolarizing ion currents, we investigated the association between an individual's QT interval and atrial effective refractory period (AERP).MethodsIn paroxysmal AF patients presenting for catheter ablation, the QT interval was measured from the surface 12-lead electrocardiogram. The AERP was defined as the longest S1-S2 coupling interval without atrial capture using a 600-ms drive cycle length.ResultsIn 28 patients, there was a positive correlation between QTc and mean AERP. After multivariate adjustment, a 1-ms increase in QTc predicted a 0.70-ms increase in AERP.ConclusionsThe QTc interval reflects the AERP, suggesting that the QTc interval may be used as a marker of atrial refractoriness relevant to assessing AF risk and mechanism-specific therapeutic strategies.
- Published
- 2016
115. Telemetry Tracing After Pacemaker Implant
- Author
-
Marcus, Gregory M., Goldschlager, Nora, Natale, Andrea, editor, Wang, Paul J., editor, Al-Ahmad, Amin, editor, and Estes, N. A. Mark, editor
- Published
- 2020
- Full Text
- View/download PDF
116. Placental Abruption as a Risk Factor for Heart Failure
- Author
-
DesJardin, Jacqueline T., Healy, Michael J., Nah, Gregory, Vittinghoff, Eric, Agarwal, Anushree, Marcus, Gregory M., Velez, Juan M. Gonzalez, Tseng, Zian H., and Parikh, Nisha I.
- Published
- 2020
- Full Text
- View/download PDF
117. Predictors of adverse outcome in patients with frequent premature ventricular complexes: The ABC-VT risk score
- Author
-
Voskoboinik, Aleksandr, Hadjis, Alexios, Alhede, Christina, Im, Sung Il, Park, Hansu, Moss, Joshua, Marcus, Gregory M., Hsia, Henry, Lee, Byron, Tseng, Zian, Lee, Randall, Scheinman, Melvin, Vedantham, Vasanth, Vittinghoff, Eric, Park, Kyoung-Min, and Gerstenfeld, Edward P.
- Published
- 2020
- Full Text
- View/download PDF
118. Effect of acute and chronic ethanol on atrial fibrillation vulnerability in rats
- Author
-
Zhang, Hao, Ruan, Hongmei, Rahmutula, Dolkun, Wilson, Emily, Marcus, Gregory M., Vedantham, Vasanth, and Olgin, Jeffrey E.
- Published
- 2020
- Full Text
- View/download PDF
119. Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
- Author
-
Durstenfeld, Matthew S., primary, Peluso, Michael J., additional, Lin, Feng, additional, Peyser, Noah D., additional, Isasi, Carmen, additional, Carton, Thomas W., additional, Henrich, Timothy J., additional, Deeks, Steven G., additional, Olgin, Jeffrey E., additional, Pletcher, Mark J., additional, Beatty, Alexis L., additional, Marcus, Gregory M., additional, and Hsue, Priscilla Y., additional
- Published
- 2024
- Full Text
- View/download PDF
120. Electrocardiographic Predictors of Incident Atrial Fibrillation
- Author
-
Nguyen, Kaylin T, Vittinghoff, Eric, Dewland, Thomas A, Mandyam, Mala C, Stein, Phyllis K, Soliman, Elsayed Z, Heckbert, Susan R, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Heart Disease ,Clinical Research ,Cardiovascular ,Good Health and Well Being ,Aged ,Atrial Fibrillation ,Atrial Premature Complexes ,Body Mass Index ,Cohort Studies ,Electrocardiography ,Female ,Humans ,Incidence ,Predictive Value of Tests ,Prevalence ,Risk Assessment ,Risk Factors ,Sensitivity and Specificity ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
Atrial fibrillation (AF) is likely secondary to multiple different pathophysiological mechanisms that are increasingly but incompletely understood. Motivated by the hypothesis that 3 previously described electrocardiographic predictors of AF identify distinct AF mechanisms, we sought to determine if these electrocardiographic findings independently predict incident disease. Among Cardiovascular Health Study participants without prevalent AF, we determined whether left anterior fascicular block (LAFB), a prolonged QTC, and atrial premature complexes (APCs) each predicted AF after adjusting for each other. We then calculated the attributable risk in the exposed for each electrocardiographic marker. LAFB and QTC intervals were assessed on baseline 12-lead electrocardiogram (n = 4,696). APC count was determined using 24-hour Holter recordings obtained in a random subsample (n = 1,234). After adjusting for potential confounders and each electrocardiographic marker, LAFB (hazard ratio [HR] 2.1, 95% confidence interval [CI] 1.1 to 3.9, p = 0.023), a prolonged QTC (HR 2.5, 95% CI 1.4 to 4.3, p = 0.002), and every doubling of APC count (HR 1.2, 95% CI 1.1 to 1.3, p
- Published
- 2016
121. Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals
- Author
-
Roberts, Jason D, Hu, Donglei, Heckbert, Susan R, Alonso, Alvaro, Dewland, Thomas A, Vittinghoff, Eric, Liu, Yongmei, Psaty, Bruce M, Olgin, Jeffrey E, Magnani, Jared W, Huntsman, Scott, Burchard, Esteban G, Arking, Dan E, Bibbins-Domingo, Kirsten, Harris, Tamara B, Perez, Marco V, Ziv, Elad, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Research ,Cardiovascular ,Human Genome ,Heart Disease ,Prevention ,Aging ,Genetics ,Atherosclerosis ,Atrial Fibrillation ,Black People ,Carrier Proteins ,Chromosomes ,Human ,Pair 10 ,Genetic Predisposition to Disease ,Humans ,Incidence ,Muscle Proteins ,Polymorphism ,Single Nucleotide ,Risk Factors ,White People ,Cardiovascular medicine and haematology - Abstract
ImportanceWhite persons have a higher risk of atrial fibrillation (AF) compared with black individuals despite a lower prevalence of risk factors. This difference may be due, at least in part, to genetic factors.ObjectivesTo determine whether 9 single-nucleotide polymorphisms (SNPs) associated with AF account for this paradoxical differential racial risk for AF and to use admixture mapping to search genome-wide for loci that may account for this phenomenon.Design, setting, and participantsGenome-wide admixture analysis and candidate SNP study involving 3 population-based cohort studies that were initiated between 1987 and 1997, including the Cardiovascular Health Study (CHS) (n = 4173), the Atherosclerosis Risk in Communities (ARIC) (n = 12 341) study, and the Health, Aging, and Body Composition (Health ABC) (n = 1015) study. In all 3 studies, race was self-identified. Cox proportional hazards regression models and the proportion of treatment effect method were used to determine the impact of 9 AF-risk SNPs among participants from CHS and the ARIC study. The present study began July 1, 2012, and was completed in 2015.Main outcomes and measuresIncident AF systematically ascertained using clinic visit electrocardiograms, hospital discharge diagnosis codes, death certificates, and Medicare claims data.ResultsA single SNP, rs10824026 (chromosome 10: position 73661450), was found to significantly mediate the higher risk for AF in white participants compared with black participants in CHS (11.4%; 95% CI, 2.9%-29.9%) and ARIC (31.7%; 95% CI, 16.0%-53.0%). Admixture mapping was performed in a meta-analysis of black participants within CHS (n = 811), ARIC (n = 3112), and Health ABC (n = 1015). No loci that reached the prespecified statistical threshold for genome-wide significance were identified.Conclusions and relevanceThe rs10824026 SNP on chromosome 10q22 mediates a modest proportion of the increased risk of AF among white individuals compared with black individuals, potentially through an effect on gene expression levels of MYOZ1. No additional genetic variants accounting for a significant portion of the differential racial risk of AF were identified with genome-wide admixture mapping, suggesting that additional genetic or environmental influences beyond single SNPs in isolation may account for the paradoxical racial risk of AF among white individuals and black individuals.
- Published
- 2016
122. Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study
- Author
-
Thadani, Samir R, Ristow, Bryan, Blackwell, Terri, Mehra, Reena, Stone, Katie L, Marcus, Gregory M, Varosy, Paul D, Cummings, Steven R, Cawthon, Peggy M, and Group, Osteoporotic Fractures in Men Study Research
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Aging ,Heart Disease ,Sleep Research ,Cardiovascular ,Clinical Research ,Aged ,Aged ,80 and over ,Atrial Fibrillation ,Atrial Flutter ,Bone Density Conservation Agents ,Diphosphonates ,Electrocardiography ,Humans ,Incidence ,Logistic Models ,Male ,Multivariate Analysis ,Osteoporosis ,Polysomnography ,Prevalence ,Proportional Hazards Models ,Prospective Studies ,Risk Factors ,Sleep Apnea Syndromes ,atrial fibrillation ,bisphosphonates ,sleep-disordered breathing ,Osteoporotic Fractures in Men Study (MrOS) Research Group ,Respiratory System ,Cardiovascular medicine and haematology ,Clinical sciences - Abstract
BackgroundPrior studies suggested an association between bisphosphonates and atrial fibrillation/flutter (AF) in women. This relationship in men, including those with sleep-disordered breathing (SDB), remains unclear. This study evaluated the relationship between bisphosphonate use and prevalent (nocturnal) and incident (clinically relevant) AF in a population of community-dwelling older men.MethodsA total of 2,911 male participants (mean age, 76 years) of the prospective observational Osteoporotic Fractures in Men Study sleep cohort with overnight in-home polysomnography (PSG) constituted the analytic cohort. Nocturnal AF from ECGs during PSG and incident AF events were centrally adjudicated. The association of bisphosphonate use and AF was examined using multivariable-adjusted logistic regression for prevalent AF and Cox proportional hazards regression for incident AF.ResultsA total of 123 (4.2%) men were current bisphosphonate users. Prevalent nocturnal AF was present in 138 participants (4.6%). After multivariable adjustment, there was a significant association between current bisphosphonate use and prevalent AF (OR, 2.33; 95% CI, 1.13-4.79). In the subset of men with moderate to severe SDB, this association was even more pronounced (OR, 3.22; 95% CI, 1.29-8.03). However, the multivariable-adjusted relationship between bisphosphonate use and incident AF did not reach statistical significance (adjusted hazard ratio, 1.53; 95% CI, 0.96-2.45).ConclusionsThese results support an association between bisphosphonate use and prevalent nocturnal AF in community-dwelling older men. The data further suggest that those with moderate to severe SDB may be a particularly vulnerable group susceptible to bisphosphonate-related AF. Similar associations were not seen for bisphosphonate use and clinically relevant incident AF.
- Published
- 2016
123. Atrial Fibrillation and Declining Physical Performance in Older Adults: The Health, Aging, and Body Composition Study.
- Author
-
Magnani, Jared W, Wang, Na, Benjamin, Emelia J, Garcia, Melissa E, Bauer, Douglas C, Butler, Javed, Ellinor, Patrick T, Kritchevsky, Stephen, Marcus, Gregory M, Newman, Anne, Phillips, Caroline L, Sasai, Hiroyuki, Satterfield, Suzanne, Sullivan, Lisa M, Harris, Tamara B, and Health, Aging, and Body Composition Study
- Subjects
Health ,Aging ,and Body Composition Study ,Humans ,Atrial Fibrillation ,Electrocardiography ,Disability Evaluation ,Prevalence ,Risk Assessment ,Risk Factors ,Follow-Up Studies ,Prospective Studies ,Motor Activity ,Age Factors ,Health Status ,Body Composition ,Aging ,Time Factors ,Aged ,Aged ,80 and over ,United States ,Female ,Male ,aging ,atrial fibrillation ,epidemiology ,medicare ,physical exercise ,Basic Behavioral and Social Science ,Clinical Research ,Cardiovascular ,Behavioral and Social Science ,Heart Disease ,Prevention ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Medical Physiology ,Cardiovascular System & Hematology - Abstract
BackgroundAge is the foremost risk factor for atrial fibrillation (AF), and AF has a rising prevalence in older adults. How AF may contribute to decline in physical performance in older adults has had limited investigation. We examined the associations of incident AF and 4-year interval declines in physical performance at ages 70, 74, 78, and 82 years in the Health, Aging, and Body Composition (Health ABC) Study.Methods and resultsHealth ABC is a prospective cohort of community-dwelling older adults (n=3075). The study conducted serial assessments of physical performance with the Health ABC physical performance battery (scored 0-4), grip strength, 2-minute walk distance, and 400-m walking time. Incident AF was identified from the Center for Medicare and Medicaid Services and related to 4-year interval decline in physical performance. After exclusions, the analysis included 2753 Health ABC participants (52% women, 41% black race). Participants with AF had a significantly greater 4-year physical performance battery decline than those without AF at age 70, 74, 78, and 82, with mean estimated decline ranging from -0.08 to -0.10 U (95% confidence interval, -0.18 to -0.01; P
- Published
- 2016
124. Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation
- Author
-
Roberts, Jason D, Dewland, Thomas A, Glidden, David V, Hoffmann, Thomas J, Arking, Dan E, Chen, Lin Y, Psaty, Bruce M, Olgin, Jeffrey E, Alonso, Alvaro, Heckbert, Susan R, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Heart Disease ,Prevention ,Clinical Research ,Hypertension ,Genetics ,Atherosclerosis ,Cardiovascular ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Good Health and Well Being ,Aged ,Angiotensin Receptor Antagonists ,Angiotensin-Converting Enzyme Inhibitors ,Atrial Fibrillation ,Female ,Genetic Variation ,Genome-Wide Association Study ,Humans ,Male ,Pharmacogenomic Testing ,Polymorphism ,Single Nucleotide ,Primary Prevention ,Proportional Hazards Models ,Renin-Angiotensin System ,Treatment Outcome ,United States ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundRenin-angiotensin system (RAS) inhibition via angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers may reduce the risk of developing atrial fibrillation (AF) in certain populations, but the evidence is conflicting. Recent genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) associated with AF, potentially identifying clinically relevant subtypes of the disease. We sought to investigate the impact of carrier status of 9 AF-associated SNPs on the efficacy of RAS inhibition for the primary prevention of AF.MethodsWe performed SNP-RAS inhibitor interaction testing with unadjusted and adjusted Cox proportional hazards models using a discovery (Cardiovascular Health Study) and a replication (Atherosclerosis Risk in Communities) cohort. Additive genetic models were used for the SNP analyses, and 2-tailed P values
- Published
- 2016
125. Proceedings from Heart Rhythm Society’s emerging technologies forum, Boston, MA, May 12, 2015
- Author
-
Zeitler, Emily P, Al-Khatib, Sana M, Slotwiner, David, Kumar, Uday N, Varosy, Paul, Van Wagoner, David R, Marcus, Gregory M, Kusumoto, Fred M, and Blum, Laura
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Research ,Cardiovascular ,Heart Disease ,Generic health relevance ,Good Health and Well Being ,Cardiology ,Equipment Design ,Heart Rate ,Humans ,Inventions ,Societies ,Medical ,United States ,Innovation ,Medical device ,Professional societies ,Biomedical Engineering ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
Physicians are in an excellent position to significantly contribute to medical device innovation, but the process of bringing an idea to the bedside is complex. To begin to address these perceived barriers, the Heart Rhythm Society convened a forum of stakeholders in medical device innovation in conjunction with the 2015 Heart Rhythm Society Annual Scientific Sessions. The forum facilitated open discussion on medical device innovation, including obstacles to physician involvement and possible solutions. This report is based on the themes that emerged. First, physician innovators must take an organized approach to identifying unmet clinical needs and potential solutions. Second, extensive funds, usually secured through solicitation for investment, are often required to achieve meaningful progress, developing an idea into a device. Third, planning for regulatory requirements of the US Food and Drug Administration and Centers for Medicare & Medicaid Services is essential. In addition to these issues, intellectual property and overall trends in health care, including international markets, are critically relevant considerations for the physician innovator. Importantly, there are a number of ways in which professional societies can assist physician innovators to navigate the complex medical device innovation landscape, bring clinically meaningful devices to market more quickly, and ultimately improve patient care. These efforts include facilitating interaction between potential collaborators through scientific meetings and other gatherings; collecting, evaluating, and disseminating state-of-the-art scientific information; and representing the interests of members in interactions with regulators and policymakers.
- Published
- 2016
126. Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study
- Author
-
Dixit, Shalini, Pletcher, Mark J, Vittinghoff, Eric, Imburgia, Kourtney, Maguire, Carol, Whitman, Isaac R, Glantz, Stanton A, Olgin, Jeffrey E, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Cardiovascular ,Cancer ,Health Effects of Indoor Air Pollution ,Clinical Research ,Tobacco Smoke and Health ,Prevention ,Tobacco ,Heart Disease ,2.3 Psychological ,social and economic factors ,Aetiology ,Adult ,Air Pollution ,Indoor ,Atrial Fibrillation ,Child ,Cross-Sectional Studies ,Demography ,Environmental Exposure ,Female ,Global Health ,Humans ,Longitudinal Studies ,Male ,Pregnancy ,Prenatal Exposure Delayed Effects ,Prevalence ,Risk Factors ,Socioeconomic Factors ,Surveys and Questionnaires ,Tobacco Smoke Pollution ,Workplace ,Arrhythmia ,Atrial fibrillation ,Epidemiology ,Lone atrial fibrillation ,Risk factors ,Secondhand smoke ,Biomedical Engineering ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundCigarette smoking is a risk factor for atrial fibrillation (AF), but whether secondhand smoke (SHS) impacts the risk of AF remains unknown.ObjectiveTo determine if SHS exposure is associated with an increased risk of AF.MethodsWe performed a cross-sectional analysis of data from participants enrolled in the Health eHeart Study, an internet-based, longitudinal cardiovascular cohort study, who completed baseline SHS exposure and medical conditions questionnaires. SHS was assessed through a validated 22-question survey, and prevalent AF was assessed by self-report, with validation of a subset (n = 42) by review of electronic medical records.ResultsOf 4976 participants, 593 (11.9%) reported having AF. In unadjusted analyses, patients with AF were more likely to have been exposed to SHS in utero, as a child, as an adult, at home, and at work. After multivariable adjustment for potential confounders, having had a smoking parent during gestational development (OR 1.37, 95% CI 1.08-1.73, P = .009) and residing with a smoker during childhood (OR 1.40, 95% CI 1.10-1.79, P = .007) were each significantly associated with AF. Both positive associations were more pronounced among patients without risk factors for AF (P values for interaction
- Published
- 2016
127. Email-Based Recruitment Into the Health eHeart Study: Cohort Analysis of Invited Eligible Patients
- Author
-
Ng, Madelena Y, primary, Olgin, Jeffrey E, additional, Marcus, Gregory M, additional, Lyles, Courtney R, additional, and Pletcher, Mark J, additional
- Published
- 2023
- Full Text
- View/download PDF
128. Cannabis use and incident atrial fibrillation in a longitudinal cohort
- Author
-
Teraoka, Justin T., primary, Tang, Janet J., additional, Delling, Francesca N., additional, Vittinghoff, Eric, additional, and Marcus, Gregory M., additional
- Published
- 2023
- Full Text
- View/download PDF
129. Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model
- Author
-
Higuchi, Satoshi, primary, Voskoboinik, Aleksandr, additional, Il Im, Sung, additional, Lee, Adam, additional, Olgin, Jeffrey, additional, Arbil, Ayla, additional, Afzal, Junaid, additional, Marcus, Gregory M., additional, Stillson, Carol, additional, Bibby, Dwight, additional, Abraham, Theodore, additional, Wilson, Emily, additional, and Gerstenfeld, Edward P., additional
- Published
- 2023
- Full Text
- View/download PDF
130. Preceding Night Sleep Quality and Atrial Fibrillation Episodes in the I-STOP-AFIB Randomized Trial
- Author
-
Wong, Christopher X., primary, Modrow, Madelaine Faulkner, additional, Sigona, Kathi, additional, Tang, Janet J., additional, Vittinghoff, Eric, additional, Hills, Mellanie True, additional, McCall, Debbe, additional, Sciarappa, Kathleen, additional, Pletcher, Mark J., additional, Olgin, Jeffrey E., additional, and Marcus, Gregory M., additional
- Published
- 2023
- Full Text
- View/download PDF
131. Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry
- Author
-
Nishimura, Marin, Marcus, Gregory M., Varosy, Paul D., Bao, Haikun, Wang, Yongfei, Curtis, Jeptha P., and Hsu, Jonathan C.
- Published
- 2020
- Full Text
- View/download PDF
132. Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults
- Author
-
Aronis, Konstantinos N, Wang, Na, Phillips, Caroline L, Benjamin, Emelia J, Marcus, Gregory M, Newman, Anne B, Rodondi, Nicolas, Satterfield, Suzanne, Harris, Tamara B, Magnani, Jared W, and study, Health ABC
- Subjects
Aging ,Prevention ,Heart Disease ,Nutrition ,Obesity ,Clinical Research ,Cardiovascular ,2.1 Biological and endogenous factors ,Aetiology ,Metabolic and endocrine ,Oral and gastrointestinal ,Cancer ,Stroke ,Aged ,Atrial Fibrillation ,Body Composition ,Body Fat Distribution ,Female ,Follow-Up Studies ,Humans ,Incidence ,Male ,Prospective Studies ,Racial Groups ,Risk Factors ,Sex Factors ,Time Factors ,United States ,Health ABC study ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
UnlabelledObesity is a well-recognized risk factor for atrial fibrillation (AF), yet adiposity measures other than body mass index (BMI) have had limited assessment in relation to AF risk. We examined the associations of adiposity measures with AF in a biracial cohort of older adults. Given established racial differences in obesity and AF, we assessed for differences by black and white race in relating adiposity and AF.MethodsWe analyzed data from 2,717 participants of the Health, Aging, and Body Composition Study. Adiposity measures were BMI, abdominal circumference, subcutaneous and visceral fat area, and total and percent fat mass. We determined the associations between the adiposity measures and 10-year incidence of AF using Cox proportional hazards models and assessed for their racial differences in these estimates.ResultsIn multivariable-adjusted models, 1-SD increases in BMI, abdominal circumference, and total fat mass were associated with a 13% to 16% increased AF risk (hazard ratio [HR] 1.14, 95% CI 1.02-1.28; HR 1.16, 95% CI 1.04-1.28; and HR 1.13, 95% CI 1.002-1.27). Subcutaneous and visceral fat areas were not significantly associated with incident AF. We did not identify racial differences in the associations between the adiposity measures and AF.ConclusionBody mass index, abdominal circumference, and total fat mass are associated with risk of AF for 10years among white and black older adults. Obesity is one of a limited number of modifiable risk factors for AF; future studies are essential to evaluate how obesity reduction can modify the incidence of AF.
- Published
- 2015
133. Accuracy and Usability of a Self-Administered 6-Minute Walk Test Smartphone Application
- Author
-
Brooks, Gabriel C, Vittinghoff, Eric, Iyer, Sivaraman, Tandon, Damini, Kuhar, Peter, Madsen, Kristine A, Marcus, Gregory M, Pletcher, Mark J, and Olgin, Jeffrey E
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Cardiovascular ,Clinical Research ,Heart Disease ,Adult ,Aged ,Aged ,80 and over ,Algorithms ,Exercise Test ,Exercise Tolerance ,Female ,Follow-Up Studies ,Heart Failure ,Humans ,Male ,Middle Aged ,Reproducibility of Results ,Smartphone ,Time Factors ,Walking ,Young Adult ,disease management ,exercise test ,heart failure ,hypertension ,mobile applications ,pulmonary ,smartphone ,telemedicine ,Biochemistry and Cell Biology ,Cardiorespiratory Medicine and Haematology ,Medical Physiology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Medical physiology - Abstract
BackgroundThe 6-minute walk test (6MWT) independently predicts congestive heart failure severity, death, and heart failure hospitalizations, but must be administered in clinic by qualified staff on a premeasured course. As part of the Health eHeart Study, we sought to develop and validate a self-administered 6MWT mobile application (SA-6MWTapp) for independent use at home by patients.Methods and resultsWe performed a validation study of an SA-6MWTapp in 103 participants. In phase 1 (n=52), we developed a distance-estimation algorithm for the SA-6MWTapp by comparing step counts from an Actigraph and measured distance on a premeasured 6MWT course with step counts and estimated distance obtained simultaneously from our SA-6MWTapp (best estimation algorithm, r=0.89 [95% confidence interval 0.78-0.99]). In phase 2, 32 participants (including those with congestive heart failure and pulmonary hypertension) used the SA-6MWTapp independently in clinic, and the distance estimated by the SA-6MWTapp was compared with the measured distance (r=0.83 [95% confidence interval 0.79-0.92]). In phase 3, 19 patients with congestive heart failure and pulmonary hypertension consecutively enrolled from clinic performed 3.2±1 SA-6MWTapp tests per week at home over 2 weeks. Distances estimated from the SA-6MWTapp during home 6MWTs were highly repeatable (coefficient of variation =4.6%) and correlated with in-clinic-measured distance (r=0.88 [95% confidence interval 0.87-0.89]). Usability surveys performed during the second (in-clinic) and third (at-home) phases demonstrated that the SA-6MWTapp was simple and easy to use independently.ConclusionsAn SA-6MWTapp is easy to use and yields accurate repeatable measurements in the clinic and at home.
- Published
- 2015
134. Perceptions, Information Sources, and Behavior Regarding Alcohol and Heart Health
- Author
-
Whitman, Isaac R, Pletcher, Mark J, Vittinghoff, Eric, Imburgia, Kourtney E, Maguire, Carol, Bettencourt, Laura, Sinha, Tuhin, Parsnick, Todd, Tison, Geoffrey H, Mulvanny, Christopher G, Olgin, Jeffrey E, and Marcus, Gregory M
- Subjects
Behavioral and Social Science ,Substance Misuse ,Cardiovascular ,Heart Disease ,Clinical Research ,Alcoholism ,Alcohol Use and Health ,Basic Behavioral and Social Science ,Good Health and Well Being ,Adult ,Age Factors ,Aged ,Alcohol Drinking ,Alcoholic Beverages ,Cardiovascular Diseases ,Cohort Studies ,Cross-Sectional Studies ,Female ,Health Knowledge ,Attitudes ,Practice ,Health Status ,Humans ,Internet ,Male ,Middle Aged ,Sex Factors ,Socioeconomic Factors ,United States ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology - Abstract
Despite the equipoise regarding alcohol's cardiovascular effects and absence of relevant rigorous controlled trials, the lay press frequently portrays alcohol as "heart healthy." The public perception of alcohol's heart effects, the sources of those perceptions, and how they may affect behavior are unknown. We performed a cross-sectional analysis of data obtained from March 2013 to September 2014 from consecutive participants enrolled in the Health eHeart Study. Of 5,582 participants, 1,707 (30%) viewed alcohol as heart healthy, 2,157 (39%) viewed it as unhealthy, and 1,718 (31%) were unsure. Of those reporting alcohol as heart healthy, 80% cited lay press as a source of their knowledge. After adjustment, older age (odds ratio 1.11), higher education (odds ratio 1.37), higher income (odds ratio 1.07), US residence (odds ratio 1.63), and coronary artery disease (odds ratio 1.51) were associated with perception of alcohol as heart healthy (all p 5,000 consecutive Health eHeart participants, approximately 1/3 believed alcohol to be heart healthy, and the majority cited the lay press as the origin of that perception. Those with a perception of alcohol as heart healthy drink substantially more alcohol.
- Published
- 2015
135. Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation Results From the Health ABC Study (Health, Aging, and Body Composition)
- Author
-
Dewland, Thomas A, Vittinghoff, Eric, Harris, Tamara B, Magnani, Jared W, Liu, Yongmei, Hsu, Fang-Chi, Satterfield, Suzanne, Wassel, Christina, Marcus, Gregory M, and Investigators, Health ABC Study
- Subjects
Cardiovascular ,Clinical Research ,Prevention ,Obesity ,Heart Disease ,Aging ,Stroke ,Inflammatory and immune system ,atrial fibrillation ,inflammation ,race ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences - Abstract
BackgroundDespite a lower prevalence of established atrial fibrillation (AF) risk factors, Whites exhibit substantially higher rates of this arrhythmia compared to Blacks. The mechanism underlying this observation is not known. Both inflammation and obesity are risk factors for AF, and adipose tissue is a known contributor to systemic inflammation.ObjectivesWe sought to determine the degree to which racial differences in AF risk are explained by differences in inflammation and adiposity.MethodsBaseline serum inflammatory biomarker concentrations and abdominal adiposity (assessed by computed tomography) were quantified in a subset of Black and White participants without prevalent AF in the Health, Aging, and Body Composition (Health ABC) Study. Participants were prospectively followed for the diagnosis of AF using study ECGs and Medicare claims data. Cox proportional hazards models were used to determine the adjusted relative hazard of incident AF between races before and after biomarker adjustment.ResultsAmong 2,768 participants (43% Black), 721 developed incident AF over a median follow up of 10.9 years. White race was associated with a heightened adjusted risk of incident AF (HR 1.55, 95% CI 1.30 to 1.84, p < 0.001). Abdominal adiposity was not associated with AF when added to the adjusted model. Among the studied biomarkers, adiponectin, TNF-α, TNF-α SR I, and TNF-α SR II concentrations were each higher among Whites and independently associated with a greater risk of incident AF. Together, these inflammatory cytokines mediated 42% (95% CI 15 to 119%, p = 0.004) of the adjusted race-AF association.ConclusionsSystemic inflammatory pathways significantly mediate the heightened risk of AF among Whites. The higher level of systemic inflammation and concomitant increased AF risk in Whites is not explained by racial differences in abdominal adiposity or the presence of other pro-inflammatory cardiovascular comorbidities.
- Published
- 2015
136. Ventricular Ectopy as a Predictor of Heart Failure and Death
- Author
-
Dukes, Jonathan W, Dewland, Thomas A, Vittinghoff, Eric, Mandyam, Mala C, Heckbert, Susan R, Siscovick, David S, Stein, Phyllis K, Psaty, Bruce M, Sotoodehnia, Nona, Gottdiener, John S, and Marcus, Gregory M
- Subjects
Cardiovascular ,Heart Disease ,Prevention ,Clinical Research ,Aging ,Good Health and Well Being ,Aged ,Catheter Ablation ,Echocardiography ,Electrocardiography ,Ambulatory ,Female ,Forecasting ,Heart Failure ,Humans ,Male ,Risk Factors ,Stroke Volume ,Ventricular Premature Complexes ,arrhythmia ,mortality ,premature ventricular contractions ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
BackgroundStudies of patients presenting for catheter ablation suggest that premature ventricular contractions (PVCs) are a modifiable risk factor for congestive heart failure (CHF). The relationship among PVC frequency, incident CHF, and mortality in the general population remains unknown.ObjectivesThe goal of this study was to determine whether PVC frequency ascertained using a 24-h Holter monitor is a predictor of a decrease in the left ventricular ejection fraction (LVEF), incident CHF, and death in a population-based cohort.MethodsWe studied 1,139 Cardiovascular Health Study (CHS) participants who were randomly assigned to 24-h ambulatory electrocardiography (Holter) monitoring and who had a normal LVEF and no history of CHF. PVC frequency was quantified using Holter studies, and LVEF was measured from baseline and 5-year echocardiograms. Participants were followed for incident CHF and death.ResultsThose in the upper quartile versus the lowest quartile of PVC frequency had a multivariable-adjusted, 3-fold greater odds of a 5-year decrease in LVEF (odds ratio [OR]: 3.10; 95% confidence interval [CI]: 1.42 to 6.77; p = 0.005), a 48% increased risk of incident CHF (HR: 1.48; 95% CI: 1.08 to 2.04; p = 0.02), and a 31% increased risk of death (HR: 1.31; 95% CI: 1.06 to 1.63; p = 0.01) during a median follow-up of >13 years. Similar statistically significant results were observed for PVCs analyzed as a continuous variable. The specificity for the 15-year risk of CHF exceeded 90% when PVCs included at least 0.7% of ventricular beats. The population-level risk for incident CHF attributed to PVCs was 8.1% (95% CI: 1.2% to 14.9%).ConclusionsIn a population-based sample, a higher frequency of PVCs was associated with a decrease in LVEF, an increase in incident CHF, and increased mortality. Because of the capacity to prevent PVCs through medical or ablation therapy, PVCs may represent a modifiable risk factor for CHF and death.
- Published
- 2015
137. Differences in Anticoagulant Therapy Prescription in Patients with Paroxysmal Versus Persistent Atrial Fibrillation
- Author
-
Hsu, Jonathan C, Chan, Paul S, Tang, Fengming, Maddox, Thomas M, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Hematology ,Clinical Trials and Supportive Activities ,Heart Disease ,Cardiovascular ,Clinical Research ,Aged ,Aged ,80 and over ,Anticoagulants ,Atrial Fibrillation ,Female ,Humans ,Male ,Middle Aged ,Multivariate Analysis ,Platelet Aggregation Inhibitors ,Practice Patterns ,Physicians' ,Risk Assessment ,Risk Factors ,Stroke ,Thromboembolism ,Atrial fibrillation ,Paroxysmal ,Persistent ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundPatients with paroxysmal and persistent atrial fibrillation experience a similar risk of thromboembolism. Therefore, consensus guidelines recommend anticoagulant therapy in those at risk for thromboembolism irrespective of atrial fibrillation classification. We sought to examine whether there are differences in rates of appropriate oral anticoagulant treatment among patients with paroxysmal vs persistent atrial fibrillation in real-world cardiology practices.MethodsWe studied 71,316 outpatients with atrial fibrillation and intermediate to high thromboembolic risk (CHADS2 score ≥2) enrolled in the American College of Cardiology PINNACLE Registry between 2008 and 2012. Using hierarchical modified Poisson regression models adjusted for patient characteristics, we examined whether anticoagulant treatment rates differed between patients with paroxysmal vs persistent atrial fibrillation.ResultsThe majority of outpatients (78.4%, n = 55,905) had paroxysmal atrial fibrillation. In both unadjusted and multivariable adjusted analyses, patients with paroxysmal atrial fibrillation were less frequently prescribed oral anticoagulant therapy than those with persistent atrial fibrillation (50.3% vs 64.2%; adjusted risk ratio [RR] 0.74; 95% confidence interval [CI], 0.72-0.76). Instead, patients with paroxysmal atrial fibrillation were prescribed more frequently only antiplatelet therapy (35.1% vs 25.0%; adjusted RR 1.77; 95% CI, 1.69-1.86) or neither antiplatelet nor anticoagulant therapy (14.6% vs 10.8%; adjusted RR 1.35; 95% CI, 1.26-1.44; P < .0001 for differences across all 3 comparisons).ConclusionsIn a large, real-world cardiac outpatient population, patients with paroxysmal atrial fibrillation with a moderate to high risk of stroke were less likely to be prescribed appropriate oral anticoagulant therapy and more likely to be prescribed less effective or no therapy for thromboembolism prevention.
- Published
- 2015
138. Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry
- Author
-
Hsu, Jonathan C, Chan, Paul S, Tang, Fengming, Maddox, Thomas M, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Administration ,Oral ,Adult ,Anticoagulants ,Atrial Fibrillation ,Female ,Guideline Adherence ,Humans ,Male ,Middle Aged ,Registries ,Thromboembolism ,Clinical Sciences ,Opthalmology and Optometry ,Public Health and Health Services ,Clinical sciences ,Health services and systems - Abstract
OBJECTIVES: We sought to investigate the prevalence and predictors of oral anticoagulation prescription among patients with atrial fibrillation (AF) at the lowest risk for thromboembolism, despite contemporary consensus guidelines that do not recommend anticoagulation therapy in this population. BACKGROUND: In young and healthy AF patients without significant thromboembolic risk factors, anticoagulant treatment carries bleeding risks that outweigh stroke prevention benefit. METHODS: Within a large contemporary registry of cardiology outpatients, we identified low-risk patients with AF meeting criteria for a contemporary consensus guideline class III indication against use of anticoagulation (age < 60 years, CHADS2 Score=0, and no structural heart disease) between 2008–2012, and a second cohort with the same criteria and a CHA2DS2-VASc Score of 0. Using hierarchical modified Poisson regression models adjusted for patient characteristics, we examined predictors of oral anticoagulation treatment in these low thromboembolic risk AF patients. RESULTS: Oral anticoagulation was prescribed in a total of 2,561 of 10,995 (23.2%) AF patients with a CHADS2 score of 0 and 1,787 of 6,730 (26.6%) AF patients with a CHA2DS2-VASc score of 0. In multivariable analysis, older age (RR 1.48 per 10 years; 95% CI, 1.41–1.56; p
- Published
- 2015
139. Targeted Deep Sequencing Reveals No Definitive Evidence for Somatic Mosaicism in Atrial Fibrillation
- Author
-
Roberts, Jason D, Longoria, James, Poon, Annie, Gollob, Michael H, Dewland, Thomas A, Kwok, Pui-Yan, Olgin, Jeffrey E, Deo, Rahul C, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Human Genome ,Cardiovascular ,Heart Disease ,Biotechnology ,Genetics ,Clinical Research ,2.1 Biological and endogenous factors ,Aetiology ,Aged ,Atrial Fibrillation ,Female ,Heart Atria ,High-Throughput Nucleotide Sequencing ,Humans ,Lymphocytes ,Male ,Middle Aged ,Mosaicism ,Mutation ,Missense ,arrhythmias ,cardiac ,atrial fibrillation ,cardiac electrophysiology ,computational biology ,genetics ,mosaicism ,Medical Biotechnology ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundStudies of ≤15 atrial fibrillation (AF) patients have identified atrial-specific mutations within connexin genes, suggesting that somatic mutations may account for sporadic cases of the arrhythmia. We sought to identify atrial somatic mutations among patients with and without AF using targeted deep next-generation sequencing of 560 genes, including genetic culprits implicated in AF, the Mendelian cardiomyopathies and channelopathies, and all ion channels within the genome.Methods and resultsTargeted gene capture and next-generation sequencing were performed on DNA from lymphocytes and left atrial appendages of 34 patients (25 with AF). Twenty AF patients had undergone cardiac surgery exclusively for pulmonary vein isolation and 17 had no structural heart disease. Sequence alignment and variant calling were performed for each atrial-lymphocyte pair using the Burrows-Wheeler Aligner, the Genome Analysis Toolkit, and MuTect packages. Next-generation sequencing yielded a median 265-fold coverage depth (interquartile range, 64-369). Comparison of the 3 million base pairs from each atrial-lymphocyte pair revealed a single potential somatic missense mutation in 3 AF patients and 2 in a single control (12 versus 11%; P=1). All potential discordant variants had low allelic fractions (range, 2.3%-7.3%) and none were detected with conventional sequencing.ConclusionsUsing high-depth next-generation sequencing and state-of-the art somatic mutation calling approaches, no pathogenic atrial somatic mutations could be confirmed among 25 AF patients in a comprehensive cardiac arrhythmia genetic panel. These findings indicate that atrial-specific mutations are rare and that somatic mosaicism is unlikely to exert a prominent role in AF pathogenesis.
- Published
- 2015
140. Telomere Length and the Risk of Atrial Fibrillation
- Author
-
Roberts, Jason D, Dewland, Thomas A, Longoria, James, Fitzpatrick, Annette L, Ziv, Elad, Hu, Donglei, Lin, Jue, Glidden, David V, Psaty, Bruce M, Burchard, Esteban G, Blackburn, Elizabeth H, Olgin, Jeffrey E, Heckbert, Susan R, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Research ,Prevention ,Heart Disease ,Genetics ,Cardiovascular ,Aging ,Aetiology ,2.1 Biological and endogenous factors ,Age Factors ,Aged ,Atrial Fibrillation ,California ,Cardiac Surgical Procedures ,Cellular Senescence ,Cross-Sectional Studies ,Female ,Genetic Predisposition to Disease ,Humans ,Incidence ,Leukocytes ,Male ,Phenotype ,Polymorphism ,Single Nucleotide ,Prospective Studies ,Risk Assessment ,Risk Factors ,Telomerase ,Telomere ,Time Factors ,aging ,atrial fibrillation ,genetics ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Medical Physiology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Clinical sciences ,Medical physiology - Abstract
BackgroundAdvanced age is the most important risk factor for atrial fibrillation (AF); however, the mechanism remains unknown. Telomeres, regions of DNA that shorten with cell division, are considered reliable markers of biological aging. We sought to examine the association between leukocyte telomere length (LTL) and incident AF in a large population-based cohort using direct LTL measurements and genetic data. To further explore our findings, we compared atrial cell telomere length and LTL in cardiac surgery patients.Methods and resultsMean LTL and the TERT rs2736100 single nucleotide polymorphism were assessed as predictors of incident AF in the Cardiovascular Health Study (CHS). Among the surgical patients, within subject comparison of atrial cell telomere length versus LTL was assessed. Among 1639 CHS participants, we observed no relationship between mean LTL and incident AF before and after adjustment for potential confounders (adjusted hazard ratio, 1.09; 95% confidence interval: 0.92-1.29; P=0.299); chronologic age remained strongly associated with AF in the same model. No association was observed between the TERT rs2736100 single nucleotide polymorphism and incident AF (adjusted hazard ratio: 0.95; 95% confidence interval: 0.88-1.04; P=0.265). In 35 cardiac surgery patients (26 with AF), atrial cell telomere length was longer than LTL (1.19 ± 0.20 versus 1.02 ± 0.25 [T/S ratio], P
- Published
- 2014
141. A Common SCN5A Variant Is Associated with PR Interval and Atrial Fibrillation Among African Americans
- Author
-
ILKHANOFF, LEONARD, ARKING, DAN E, LEMAITRE, ROZENN N, ALONSO, ALVARO, CHEN, LIN Y, DURDA, PETER, HESSELSON, STEPHANIE E, KERR, KATHLEEN F, MAGNANI, JARED W, MARCUS, GREGORY M, SCHNABEL, RENATE B, SMITH, J GUSTAV, SOLIMAN, ELSAYED Z, REINER, ALEXANDER P, SOTOODEHNIA, NONA, and Investigators, on behalf of the Candidate‐Gene Association Resource Consortium and the Cardiac Arrest Blood Study
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Research ,Atherosclerosis ,Cardiovascular ,Heart Disease ,Good Health and Well Being ,Adult ,Black or African American ,Aged ,Aged ,80 and over ,Atrial Fibrillation ,Case-Control Studies ,Cohort Studies ,Death ,Sudden ,Cardiac ,Female ,Genetic Variation ,Humans ,Male ,Middle Aged ,NAV1.5 Voltage-Gated Sodium Channel ,Prospective Studies ,Risk Factors ,Single-Blind Method ,atrial fibrillation ,electrocardiogram ,genetics ,PR interval ,sudden death ,Candidate-Gene Association Resource (CARE) Consortium and the Cardiac Arrest Blood Study (CABS) Investigators ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
ObjectiveWe examined the association of rs7626962 (S1103Y) or rs7629265, a variant in high linkage disequilibrium with S1103Y (r(2) = 0.87 - 1), with sudden cardiac death (SCD) and atrial fibrillation (AF) among African Americans.BackgroundThe SCN5A missense variant S1103Y has been associated with SCD among African Americans in small case-control studies, but larger population-based studies are needed to validate these findings. The association of this variant with AF has not been fully explored.MethodsUsing genotyping data on over 7,000 African Americans from 5 cohorts (Atherosclerosis Risk in Communities [ARIC], Cleveland Family Study [CFS], Jackson Heart Study [JHS], Multi-Ethnic Study of Atherosclerosis [MESA], Cardiovascular Health Study [CHS]), we examined the association of rs7629265 with electrocardiographic PR, QRS, and QT intervals, and with incident AF and SCD. We examined association of S1103Y (rs7626962) with SCD using a population-based case-control study of SCD Cardiac Arrest Blood Study (CABS).ResultsMeta-analyses across 5 cohorts demonstrated that rs7629265 was significantly associated with PR duration (β = -4.1 milliseconds; P = 2.2×10(-6) ), but not significantly associated with QRS or QT intervals. In meta-analyses of prospectively followed ARIC and CHS participants (n = 3,656), rs7629265 was associated with increased AF risk (n = 299 AF cases; HR = 1.74, P = 1.9 × 10(-4) ). By contrast, rs7629265 was not significantly associated with SCD risk in ARIC (n = 83 SCD cases; P = 0.30) or CHS (n = 54 SCD cases; P = 0.47). Similarly, S1103Y was not significantly associated with SCD risk in CABS (n = 225 SCD cases; P = 0.29).ConclusionThe common SCN5A variant, rs7629265, is associated with increased AF risk and shorter PR interval among African Americans. In contrast to prior reports, we found no evidence of association of rs7629265 or rs7626962 (S1103Y) with SCD risk in the general population.
- Published
- 2014
142. Patient-reported triggers of paroxysmal atrial fibrillation
- Author
-
Groh, Christopher A., Faulkner, Madelaine, Getabecha, Shiffen, Taffe, Victoria, Nah, Gregory, Sigona, Kathi, McCall, Debbe, Hills, Mellanie True, Sciarappa, Kathleen, Pletcher, Mark J., Olgin, Jeffrey E., and Marcus, Gregory M.
- Published
- 2019
- Full Text
- View/download PDF
143. Impact of a 4q25 Genetic Variant in Atrial Flutter and on the Risk of Atrial Fibrillation After Cavotricuspid Isthmus Ablation
- Author
-
Roberts, Jason D, Hsu, Jonathan C, Aouizerat, Bradley E, Pullinger, Clive R, Malloy, Mary J, Kane, John P, Olgin, Jeffrey E, and Marcus, Gregory M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Heart Disease ,Clinical Research ,Genetics ,Cardiovascular ,Aetiology ,2.1 Biological and endogenous factors ,Adult ,Aged ,Atrial Fibrillation ,Atrial Flutter ,Catheter Ablation ,Chromosomes ,Human ,Pair 4 ,Female ,Follow-Up Studies ,Genetic Association Studies ,Genetic Variation ,Humans ,Male ,Middle Aged ,Polymorphism ,Single Nucleotide ,Risk Factors ,Treatment Outcome ,Tricuspid Valve ,atrial fibrillation ,atrial flutter ,catheter ablation ,genetics ,molecular biology ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundThe prediction of atrial fibrillation (AF) following catheter ablation of atrial flutter (Afl) would be helpful to facilitate targeted arrhythmia monitoring and anti-coagulation strategies. A single nucleotide polymorphism, rs2200733, is strongly associated with AF. We sought to characterize the association between rs2200733 and prevalent Afl and to determine if the variant could predict AF after cavotricuspid isthmus ablation.Methods and resultsWe performed a genetic association study of 295 patients with Afl and/or AF and 469 controls using multivariable logistic regression. The variant was then assessed as a predictor of incident AF after cavotricuspid isthmus ablation in 87 consecutive typical Afl patients with Cox proportional hazards models. The rs2200733 rare allele was associated with an adjusted 2.06-fold increased odds of isolated Afl (95% CI: 1.13-3.76, P = 0.019) and an adjusted 2.79-fold increased odds of a combined phenotype of AF and Afl (95% CI: 1.81-4.28, P < 0.001). Following catheter ablation for Afl, carrier status of rs2200733 failed to predict an increased risk of AF either among all subjects (adjusted HR: 0.94; 95% CI: 0.58-1.53, P = 0.806) or among those with isolated Afl (adjusted HR: 1.29; 95% CI: 0.51-3.26, P = 0.585).ConclusionsOur study demonstrates that Afl, whether occurring in isolation or along with AF, is associated with the rs2200733 AF risk allele. Genetic carrier status of rs2200733 failed to predict an increased risk of incident or recurrent AF following catheter ablation for Afl. These findings suggest that the causal mechanism associated with rs2200733 is germane to both AF and Afl.
- Published
- 2014
144. Heart Disease and Stroke Statistics—2014 Update
- Author
-
Go, Alan S, Mozaffarian, Dariush, Roger, Véronique L, Benjamin, Emelia J, Berry, Jarett D, Blaha, Michael J, Dai, Shifan, Ford, Earl S, Fox, Caroline S, Franco, Sheila, Fullerton, Heather J, Gillespie, Cathleen, Hailpern, Susan M, Heit, John A, Howard, Virginia J, Huffman, Mark D, Judd, Suzanne E, Kissela, Brett M, Kittner, Steven J, Lackland, Daniel T, Lichtman, Judith H, Lisabeth, Lynda D, Mackey, Rachel H, Magid, David J, Marcus, Gregory M, Marelli, Ariane, Matchar, David B, McGuire, Darren K, Mohler, Emile R, Moy, Claudia S, Mussolino, Michael E, Neumar, Robert W, Nichol, Graham, Pandey, Dilip K, Paynter, Nina P, Reeves, Matthew J, Sorlie, Paul D, Stein, Joel, Towfighi, Amytis, Turan, Tanya N, Virani, Salim S, Wong, Nathan D, Woo, Daniel, and Turner, Melanie B
- Subjects
American Heart Association ,Cardiology ,Heart Diseases ,Humans ,Stroke ,United States ,AHA Scientific Statements ,cardiovascular diseases ,epidemiology ,risk factors ,statistics ,stroke ,American Heart Association Statistics Committee and Stroke Statistics Subcommittee ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease and Stroke Statistical Update. The Statistical Update is a critical resource for researchers, clinicians, healthcare policy makers, media professionals, the lay public, and many others who seek the best available national data on heart disease, stroke, and other cardiovascular disease-related morbidity and mortality and the risks, quality of care, use of medical procedures and operations, and costs associated with the management of these diseases in a single document. Indeed, since 1999, the Statistical Update has been cited >10 500 times in the literature, based on citations of all annual versions. In 2012 alone, the various Statistical Updates were cited ≈3500 times (data from Google Scholar). In recent years, the Statistical Update has undergone some major changes with the addition of new chapters and major updates across multiple areas, as well as increasing the number of ways to access and use the information assembled. For this year's edition, the Statistics Committee, which produces the document for the AHA, updated all of the current chapters with the most recent nationally representative data and inclusion of relevant articles from the literature over the past year. This year's edition includes a new chapter on peripheral artery disease, as well as new data on the monitoring and benefits of cardiovascular health in the population, with additional new focus on evidence-based approaches to changing behaviors, implementation strategies, and implications of the AHA's 2020 Impact Goals. Below are a few highlights from this year's Update. © 2013 American Heart Association, Inc.
- Published
- 2014
145. Executive Summary
- Author
-
Go, Alan S, Mozaffarian, Dariush, Roger, Véronique L, Benjamin, Emelia J, Berry, Jarett D, Blaha, Michael J, Dai, Shifan, Ford, Earl S, Fox, Caroline S, Franco, Sheila, Fullerton, Heather J, Gillespie, Cathleen, Hailpern, Susan M, Heit, John A, Howard, Virginia J, Huffman, Mark D, Judd, Suzanne E, Kissela, Brett M, Kittner, Steven J, Lackland, Daniel T, Lichtman, Judith H, Lisabeth, Lynda D, Mackey, Rachel H, Magid, David J, Marcus, Gregory M, Marelli, Ariane, Matchar, David B, McGuire, Darren K, Mohler, Emile R, Moy, Claudia S, Mussolino, Michael E, Neumar, Robert W, Nichol, Graham, Pandey, Dilip K, Paynter, Nina P, Reeves, Matthew J, Sorlie, Paul D, Stein, Joel, Towfighi, Amytis, Turan, Tanya N, Virani, Salim S, Wong, Nathan D, Woo, Daniel, and Turner, Melanie B
- Subjects
American Heart Association ,Cardiology ,Heart Diseases ,Humans ,Prevalence ,Research Report ,Risk Factors ,Stroke ,United States ,AHA Scientific Statements ,cardiovascular diseases ,epidemiology ,risk factors ,statistics ,stroke ,American Heart Association Statistics Committee and Stroke Statistics Subcommittee ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease and Stroke Statistical Update. The Statistical Update is a critical resource for researchers, clinicians, healthcare policy makers, media professionals, the lay public, and many others who seek the best available national data on heart disease, stroke, and other cardiovascular disease-related morbidity and mortality and the risks, quality of care, use of medical procedures and operations, and costs associated with the management of these diseases in a single document. Indeed, since 1999, the Statistical Update has been cited >10 500 times in the literature, based on citations of all annual versions. In 2012 alone, the various Statistical Updates were cited ≈3500 times (data from Google Scholar). In recent years, the Statistical Update has undergone some major changes with the addition of new chapters and major updates across multiple areas, as well as increasing the number of ways to access and use the information assembled. For this year's edition, the Statistics Committee, which produces the document for the AHA, updated all of the current chapters with the most recent nationally representative data and inclusion of relevant articles from the literature over the past year. This year's edition includes a new chapter on peripheral artery disease, as well as new data on the monitoring and benefits of cardiovascular health in the population, with additional new focus on evidence-based approaches to changing behaviors, implementation strategies, and implications of the AHA's 2020 Impact Goals. Below are a few highlights from this year's Update. © 2013 American Heart Association, Inc.
- Published
- 2014
146. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.
- Author
-
Go, Alan S, Mozaffarian, Dariush, Roger, Véronique L, Benjamin, Emelia J, Berry, Jarett D, Blaha, Michael J, Dai, Shifan, Ford, Earl S, Fox, Caroline S, Franco, Sheila, Fullerton, Heather J, Gillespie, Cathleen, Hailpern, Susan M, Heit, John A, Howard, Virginia J, Huffman, Mark D, Judd, Suzanne E, Kissela, Brett M, Kittner, Steven J, Lackland, Daniel T, Lichtman, Judith H, Lisabeth, Lynda D, Mackey, Rachel H, Magid, David J, Marcus, Gregory M, Marelli, Ariane, Matchar, David B, McGuire, Darren K, Mohler, Emile R, Moy, Claudia S, Mussolino, Michael E, Neumar, Robert W, Nichol, Graham, Pandey, Dilip K, Paynter, Nina P, Reeves, Matthew J, Sorlie, Paul D, Stein, Joel, Towfighi, Amytis, Turan, Tanya N, Virani, Salim S, Wong, Nathan D, Woo, Daniel, Turner, Melanie B, and American Heart Association Statistics Committee and Stroke Statistics Subcommittee
- Subjects
American Heart Association Statistics Committee and Stroke Statistics Subcommittee ,Humans ,Heart Diseases ,Prevalence ,Risk Factors ,Cardiology ,American Heart Association ,United States ,Stroke ,Research Report ,AHA Scientific Statements ,cardiovascular diseases ,epidemiology ,risk factors ,statistics ,stroke ,Cardiovascular System & Hematology ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Public Health and Health Services - Published
- 2014
147. Predictors and possible mechanisms of premature ventricular contraction induced cardiomyopathy.
- Author
-
Pundi, Krishna and Marcus, Gregory M.
- Subjects
- *
ARRHYTHMIA treatment , *RISK assessment , *CAFFEINE , *CARDIOMYOPATHIES , *ABLATION techniques , *CARDIOVASCULAR diseases risk factors , *ARRHYTHMIA , *VENTRICULAR tachycardia , *ELECTROPHYSIOLOGY , *BIOMARKERS , *DISEASE complications - Abstract
Premature ventricular complexes (PVCs) are encountered frequently in clinical practice. While PVCs may have various causes, a small number of individuals with PVCs develop cardiomyopathy in the absence of other potential etiologies. When correctly identified, patients with PVC‐incuded cardiomyopathy can have dramatic improvement of their cardiomyopathy with treatment of their PVCs. In this focused review, we discuss potential predictors of PVC‐induced cardiomyopathy, including PVC frequency, PVC characteristics, and modifiable patient risk factors. We also review some proposed mechanisms of PVC‐induced cardiomyopathy and conclude with future directions for research and clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
148. Predictors and possible mechanisms of premature ventricular contraction induced cardiomyopathy
- Author
-
Pundi, Krishna, primary and Marcus, Gregory M., additional
- Published
- 2023
- Full Text
- View/download PDF
149. Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
- Author
-
Hahn, Judith A., primary, Fatch, Robin, additional, Barnett, Nancy P., additional, and Marcus, Gregory M., additional
- Published
- 2023
- Full Text
- View/download PDF
150. An unruly case of atrioventricular block
- Author
-
Tooley, James E., primary, Marcus, Gregory M., additional, and Scheinman, Melvin, additional
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.